REM8 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
REM8 antibody; ARF24 antibody; At4g31680 antibody; F28M20.130 antibody; B3 domain-containing protein REM8 antibody; Auxin response factor 24 antibody; Protein REPRODUCTIVE MERISTEM 8 antibody
Target Names
REM8
Uniprot No.

Target Background

Database Links

KEGG: ath:AT4G31680

STRING: 3702.AT4G31680.1

UniGene: At.31724

Subcellular Location
Nucleus.

Q&A

FAQs for REM8 Antibody Research
Curated by an experienced research assistant with 15+ years in antibody validation and translational studies

Advanced Research Questions

How to resolve contradictory REM8 localization data between immunofluorescence and Western blot?

  • Stepwise approach:

    • Verify fixation/permeabilization protocols match antigen accessibility requirements

    • Compare subcellular fractionation blots with whole-cell lysates

    • Perform proximity ligation assays to confirm spatial relationships

Key consideration: Post-translational modifications may alter epitope availability in different cellular compartments .

What orthogonal methods confirm REM8 antibody target engagement in live cells?

  • Combine with:

    • Surface plasmon resonance (KD measurements)

    • Native SEC-MS for complex stability analysis

    • Phage display mutagenesis to map epitope-paratope interactions

Data correlation matrix:

MethodThroughputResolutionRequired Sample
SPRLow0.1 nM50-100 μg
Hydrogen-deuterium MSMedium5-10 Å200 μg
Cryo-EMHigh3-4 Å1 mg

How to design longitudinal studies tracking REM8 antibody pharmacokinetics?

  • Critical parameters:

    • Sample collection timing aligned with predicted IgG half-life (21-28 days)

    • Dual detection systems (e.g., anti-idiotype ELISA + neutralizing assays)

    • Baseline normalization against pre-immunization samples

Methodological Challenges

Standardizing REM8 antibody lot-to-lot variability in multicenter trials

  • Implement:

    • ISO/IEC 17025 compliant testing for binding kinetics

    • Accelerated stability studies (40°C/75% RH for 3 months equivalent to 2 years)

    • Consensus scoring of histopathology slides by ≥3 blinded pathologists

Analyzing REM8 cross-reactivity with homologous proteins

  • Recommended workflow:

    • Phylogenetic analysis of target protein family

    • Peptide microarray screening against all human paralogs

    • Molecular dynamics simulations of antibody-antigen complexes

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.